Alzheimer’s Drug Discovery Foundation (ADDF) – Letter of intent
| Name: |
Alzheimer’s Drug Discovery Foundation (ADDF) – Letter of intent Application deadline: 29/09/23 |
|---|---|
| General description: |
* Drug Development: Up to $5M. * Neuroimaging and CSF Biomarker: $600K for 1 year *Prevention: epidemiological studies $50K-$100K for 1 year. Up to $5,000,000 for clinical trials based on stage and scope of research. Please note overhead is not covered. https://www.alzdiscovery.org/research-and-grants/funding-opportunities |
| Source: | Foreign |
| Contact person: | Robi, 2152, robertg@trdf.technion.ac.il; Iris, 1272 irisbr@campus.technion.ac.il; Orly, 1588, bakarev@trdf.technion.ac.il |
| Fields: | Life Sciences and medicine |
| Type of fund: | The fund is not a competitive fund |
| Related fund and profiles: | Alzheimer’s Drug Discovery Foundation - ADDF ,Access available for Technion staff. Please sign in to see the Agency profiles (upper left corner) |